ZYME

Zymeworks Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 5/10
  • Value 0/10
Zymeworks sales and earnings growth
ZYME Growth
Neutral
  • Revenue Y/Y -17.90%
  • EPS Y/Y 8.67%
  • FCF Y/Y 0.74%
Zymeworks gross and profit margin trends
ZYME Profitability
Low
  • Gross margin 100.00%
  • EPS margin -126.30%
  • ROIC 5Y -12.77%
Zymeworks net debt vs free cash flow
ZYME Risk
Good
  • Debt / Equity 1.6
  • Debt / FCF 0.3
  • Interest coverage -49.3

Zymeworks stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Biotechnology stocks